Abdullah Omar, MD
Clinical Cardiac Electrophysiology · Atlanta, GANPI 1891059614
Payments from drug & device makers
What this record shows
28 manufacturers reported payments, led by Medtronic at 30.8% of the total. Reporting peaked in 2022 at $5,140 and has fallen 70.7% since, to $1,506 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in GA, where the typical reported total is $21,716.
Across 292 payments — averaging $49.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$3K
- Abbott$2K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$2K
- Atricure, Inc.$359
- plus $1K from 22 others
What the payments were for
- Travel & lodging$6,32544%
- Food & beverage$8,21156%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 44 | $4,470 |
| Boston Scientific | 37 | $3,093 |
| Abbott | 30 | $1,836 |
| Biotronik Inc. | 5 | $1,828 |
| Biosense Webster, Inc. | 111 | $1,520 |
| Atricure, Inc. | 7 | $359 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $332 |
| Cardiva Medical, Inc. | 13 | $237 |
| Novartis | 6 | $147 |
| Cordis US CORP. | 6 | $112 |
| Intuitive Surgical | 1 | $72 |
| E.r. Squibb & Sons, L.L.C. | 3 | $70 |
| Cvrx, Inc. | 2 | $68 |
| Pfizer | 3 | $64 |
| W. L. Gore & Associates, Inc. | 1 | $42 |
| Baxter Healthcare | 2 | $34 |
| Amgen | 2 | $30 |
| Edwards Lifesciences | 1 | $27 |
| Novo Nordisk | 1 | $24 |
| Vektor Medical Inc. | 1 | $24 |
| Merck | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Bayer | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $14 |
| Irhythm Technologies, Inc. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$1,777
- Merlin Connectivity and Remote$597
- S-ICD System Magnet$402
- Micra$315
- ASSURITY$264
- Confirm Rx$227
- Claria MRI$171
- Carto 3$145
- QDOT MICRO Catheter$143
- ATRICLIP LAA EXCLUSION SYSTEM$134
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$134
- EP-WorkNet Module$129
- FINELINE II Sterox$125
- Agilis HisPro$112
- COBALT DR MRI SURESCAN$112
- LifeVest$101
How this compares
$14,535 in reported general payments places this provider in the 45th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 540 | $541,973 |
| XareltoRivaroxaban | 129 | $132,962 |
| MultaqDronedarone Hcl | 38 | $58,089 |
| Dofetilide | 150 | $31,107 |
| EntrestoSacubitril/Valsartan | 15 | $14,895 |
| FarxigaDapagliflozin Propanediol | 12 | $6,868 |
| Metoprolol Succinate | 423 | $6,189 |
| Flecainide Acetate | 94 | $3,735 |
| Amiodarone Hcl | 84 | $1,773 |
| Mexiletine Hcl | 13 | $1,602 |
| SotalolSotalol Hcl | 78 | $1,326 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 42 | $1,100 |
| Carvedilol | 97 | $844 |
| Propranolol Hcl ErPropranolol Hcl | 11 | $438 |
| Digoxin | 11 | $434 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $64 | $541,973540 claims |
| NovartisEntresto | $147 | $14,89515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Atlanta
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- Michael LloydAtlanta$221K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Bruce StamblerAtlanta$91K
- Stacy WestermanAtlanta$60K
- Ashish BhimaniAtlanta$51K
- Aaron RichardsonAtlanta$51K
- Devinder DhindsaAtlanta$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.